Back to results
US 2004/0170632 A1Published application
Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
OwnerHanns Christian Mahler, Robert Muller +3inventors
InventorsHanns Christian Mahler, Robert Muller, Ulrike Martini-Marr, Udo Haas, Christiane Bachmann
Life of this patent
Estimating the term…
Abstract
The invention relates to a stable liquid pharmaceutical formulation comprising Cetuximab®, a chimeric monoclonal antibody against the receptor of endothelial growth factor (EGF receptor). The formulation has increased storage stability and can be used parenterally for the treatment of tumours.
Claims10
Liquid pharmaceutical formulation comprising Cetuximab®, a phosphate buffer pH 6 to pH 8 and a polyoxyethylene sorbitan fatty acid ester.
Dependencies are inferred from the claim text.